Related Experiment Video
Updated: Oct 4, 2025

12:23
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
Published on: September 7, 2022
1.8K
Targeting a conserved structural element from the SARS-CoV-2 genome using l-DNA aptamers
Jing Li1, Jonathan T Sczepanski1
1Department of Chemistry, Texas A&M University College Station TX USA jon.sczepanski@chem.tamu.edu.
RSC Chemical Biology
|February 7, 2022
Summary
Researchers developed l-DNA aptamers targeting the SARS-CoV-2 s2m RNA structure for COVID-19 diagnosis and therapy. These aptamers show high affinity and selectivity, offering potential for new antiviral tools.
Area of Science:
- Molecular Biology
- Virology
- Biotechnology
Background:
- COVID-19 pandemic caused by SARS-CoV-2.
- Focus on viral proteins, but RNA structures are also potential targets.
- SARS-CoV-2 stem-loop II-like motif (s2m) is conserved and has diagnostic/therapeutic potential.
Purpose of the Study:
- Identify high-affinity l-DNA aptamers against the SARS-CoV-2 s2m RNA.
- Evaluate aptamer selectivity and potential for diagnostic and therapeutic applications.
Main Methods:
- Selection and optimization of l-DNA aptamers (l-C1t and l-C3t) against s2m RNA.
- Binding affinity (Kd) measurements using nanomolar range.
- Assessing selectivity against monomeric s2m, homodimer duplex, and related viral RNAs (SARS-CoV-1).
- Analyzing conformational changes induced by aptamer binding.
Main Results:
- Optimized aptamers l-C1t and l-C3t bind s2m RNA with nanomolar affinity.
- Aptamers selectively differentiate monomeric s2m from its homodimer.
- Aptamers distinguish between SARS-CoV-2 and SARS-CoV-1 s2m RNAs.
- Aptamer binding induces significant conformational changes in s2m structure.
Conclusions:
- l-DNA aptamers are feasible tools for targeting SARS-CoV-2 RNA structures.
- l-C1t and l-C3t aptamers offer potential for COVID-19 diagnosis and treatment.
- Nuclease resistance and selectivity of l-aptamers enable development of novel probes for s2m function analysis.

